NDAORALTABLET
Approved
Dec 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 16h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TIMOLIDE 10-25 is a fixed-dose combination tablet containing hydrochlorothiazide (a thiazide diuretic) and timolol maleate (a non-selective beta-blocker) approved in 1981 for oral administration. It treats hypertension by combining two complementary mechanisms: diuretic sodium/water reduction and beta-adrenergic blockade. This combination therapy targets patients requiring dual antihypertensive action.
LOE Approaching
As loss of exclusivity approaches, expect team consolidation and shift toward generic transition support, defensive market maintenance, and lifecycle extension strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
TIMOLIDE represents a legacy maintenance asset with minimal hiring; career opportunity lies in defensive brand management, managed care strategy, and orchestrating generic transition rather than growth or innovation. Professionals joining this team should expect focus on retention, compliance, and lifecycle optimization in a mature, declining market.
Brand ManagerMedical Science Liaison
Worked on TIMOLIDE 10-25 at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.